Experimental data have shown that LINC00240 and LOXL2 possibly compete for miR-26b-5p binding [14], and overexpression of miR-26b-5p served as a poor prognostic marker in the subtype 2 of ESCC. The gene discussed is LOXL2; the disease is esophageal squamous cell carcinoma.